# Occidental Petroleum Corp: overview

OXY · NYSE · CIK 797468 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oxy.md) · [Financials](/companies/oxy/financials.md) · [Filings](/companies/oxy/filings.md) · [Insiders](/companies/oxy/insiders.md)

Latest reported revenue: [$7.05bn](/filings/0001628280-26-053388.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-053388).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,020](/filings/0001628280-25-051071.md) | [2,157 d](/filings/0001628280-26-009059.md) | [5,813](/filings/0001628280-26-030584.md) | [5,163](/filings/0001628280-26-053388.md) | [6,682](/filings/0001628280-25-051071.md) | [1,658 d](/filings/0001628280-26-009059.md) | [5,569](/filings/0001628280-26-030584.md) | [7,053](/filings/0001628280-26-053388.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [16.2%](/filings/0001628280-25-051071.md) | [(5.6%) d](/filings/0001628280-26-009059.md) | [16.3%](/filings/0001628280-26-030584.md) | [9.1%](/filings/0001628280-26-053388.md) | [12.6%](/filings/0001628280-25-051071.md) | [6.9% d](/filings/0001628280-26-009059.md) | [60.3%](/filings/0001628280-26-030584.md) | [42.5%](/filings/0001628280-26-053388.md) |
| Diluted EPS | $ per share | [0.98](/filings/0001628280-25-051071.md) | not reported | [0.77](/filings/0001628280-26-030584.md) | [0.26](/filings/0001628280-26-053388.md) | [0.65](/filings/0001628280-25-051071.md) | not reported | [3.13](/filings/0001628280-26-030584.md) | [2.75](/filings/0001628280-26-053388.md) |
| Free cash flow | $m | [1,999 d](/filings/0001628280-25-051071.md) | [2,330 d](/filings/0001628280-26-009059.md) | [466](/filings/0001628280-26-030584.md) | [1,255 d](/filings/0001628280-26-053388.md) | [503 d](/filings/0001628280-25-051071.md) | [1,881 d](/filings/0001628280-26-009059.md) | [(273)](/filings/0001628280-26-030584.md) | [2,682 d](/filings/0001628280-26-053388.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [26.0](/filings/0000797468-24-000034.md) | [36.2](/filings/0000797468-25-000029.md) | [23.2](/filings/0001628280-26-009059.md) | [22.7](/filings/0001628280-26-009059.md) | [21.6](/filings/0001628280-26-009059.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.9%](/filings/0000797468-24-000034.md) | [36.7%](/filings/0000797468-24-000034.md) | [20.2%](/filings/0000797468-24-000034.md) | [13.6%](/filings/0001628280-26-009059.md) | [11.0%](/filings/0001628280-26-009059.md) |
| Diluted EPS | $ per share | [1.58](/filings/0000797468-24-000034.md) | [12.40](/filings/0000797468-25-000029.md) | [3.90](/filings/0001628280-26-009059.md) | [2.44](/filings/0001628280-26-009059.md) | [1.61](/filings/0001628280-26-009059.md) |
| Free cash flow | $bn | [7.6](/filings/0000797468-24-000034.md) | [12.3](/filings/0000797468-25-000029.md) | [6.6](/filings/0001628280-26-009059.md) | [5.2](/filings/0001628280-26-009059.md) | [4.1](/filings/0001628280-26-009059.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/oxy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Berkshire Hathaway Inc](/funds/1067983.md) | 2026-06-30 | $12.87bn | 264,941,431 |  | Unchanged |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $3.53bn | 72,764,944 |  | Reduced −1,320,628 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.71bn | 55,855,049 |  | Added +3,217,238 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.34bn | 48,097,126 |  | Added +684,150 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.25bn | 46,141,269 |  | Added +2,870,472 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.92bn | 39,510,431 |  | Added +3,325,232 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $962.8m | 19,900,735 |  | Added +531,841 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $619.0m | 12,745,004 |  | Added +5,183,129 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $594.5m | 12,240,048 |  | Added +1,263,361 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $557.3m | 11,473,188 |  | Added +2,754,254 |

## Recent filings

[All 1,492 filings](/companies/oxy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 11:01 ET | [8-K](/filings/0001628280-26-065586.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-065586 |
| 2026-08-05 | 20:18 ET | [10-Q](/filings/0001628280-26-053388.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053388 |
| 2026-08-05 | 20:16 ET | [8-K](/filings/0001628280-26-053377.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053377 |
| 2026-07-10 | 20:15 ET | [8-K](/filings/0001628280-26-047886.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-047886 |
| 2026-05-05 | 20:18 ET | [10-Q](/filings/0001628280-26-030584.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030584 |
| 2026-05-05 | 20:16 ET | [8-K](/filings/0001628280-26-030567.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030567 |
| 2026-05-04 | 21:20 ET | [8-K](/filings/0000950157-26-000569.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950157-26-000569 |
| 2026-04-10 | 11:15 ET | [8-K](/filings/0001628280-26-024581.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-024581 |
| 2026-03-19 | 20:18 ET | [DEF 14A](/filings/0001628280-26-019816.md) | Proxy statement, period 2025-12-31 | 0001628280-26-019816 |
| 2026-03-09 | 20:19 ET | [8-K](/filings/0000950157-26-000265.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950157-26-000265 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-009059.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 797468
- Tickers: OXY, OXY-WT
- Exchange: NYSE
- SIC code: 1311 Crude Petroleum & Natural Gas
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.